Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CHILL BRANDS GROUP PLC M&A Activity 2020

Aug 3, 2020

4943_tar_2020-08-03_61c8fce4-e154-4533-9ead-6ccdd9aa7f66.html

M&A Activity

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 8965U

Zoetic International PLC

03 August 2020

3 August 2020

Zoetic International plc

("Zoetic" or the "Company")

Update on Sale of DT Ultravert ("DTU") Interest and Kansas Nitrogen Assets

Zoetic International plc (LSE: ZOE), the London-listed vertically integrated CBD and natural resources company, provides a further update on the sale of DTU and its Kansas nitrogen assets to Path Investments plc ("Path"), as previously announced on 27 May 2020 and 8 July 2020 (the "Transaction").

The Transaction has not yet completed due to matters beyond the Company's and Path's control, but the Board remains hopeful that matters will be concluded shortly.  The Company and Path have agreed an extension to allow the Transaction to complete.  The delay in completion of the Transaction has no material impact on the financial performance of the Company.

Enquiries

Zoetic International plc                                                                                                      c/o IFC Advisory

Trevor Taylor, Co-CEO

Allenby Capital Limited (Financial Adviser and Broker)                                            +44 (0) 20 3328 5656

Nick Harriss (Corporate Finance)

Nick Naylor (Corporate Finance)

Guy McDougall (Equity Sales)

IFC Advisory Ltd (Financial PR and IR)                                                                          +44 (0) 20 3934 6630

Tim Metcalfe

Graham Herring

Florence Chandler

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

UPDUPUQCRUPUUCW